Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Phase II study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel as first-line therapy for advanced gastric cancer.
Matsubara J, Shimada Y, Kato K, Nagai Y, Iwasa S, Nakajima TE, Hamaguchi T, Yamada Y, Takagi S, Kobayashi K, Yoshioka A, Nakayama N, Tsuji A.
Oncology. 2011;81(5-6):291-7. Epub 2011 Nov 30.
Related citations
Docetaxel plus oxaliplatin in combination with capecitabine as first-line treatment for advanced gastric cancer.
Amarantidis K, Xenidis N, Chelis L, Chamalidou E, Dimopoulos P, Michailidis P, Tentes A, Deftereos S, Karanikas M, Karayiannakis A, Kakolyris S.
Oncology. 2011;80(5-6):359-65. Epub 2011 Jul 29.
Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy.
Tamura S, Fujitani K, Kimura Y, Tsuji T, Matsuyama J, Iijima S, Imamura H, Inoue K, Kobayashi K, Kurokawa Y, Furukawa H; Osaka Gastrointestinal Cancer Chemotherapy Study Group.
Oncology. 2011;80(5-6):296-300. Epub 2011 Jul 18.
Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer.
Shi C, Yang B, Chen Q, Yang J, Fan N.
Oncology. 2011;80(5-6):289-95. Epub 2011 Jul 18.
A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis.
Park HS, Rha SY, Kim HS, Hyung WJ, Park JS, Chung HC, Noh SH, Jeung HC.
Oncology. 2011;80(1-2):142-50. Epub 2011 Jun 15.
Prognostic impact of phosphorylated mitogen-activated protein kinase expression in patients with metastatic gastric cancer.
Atmaca A, Pauligk C, Steinmetz K, Altmannsberger HM, Jäger E, Al-Batran SE.
Oncology. 2011;80(1-2):130-4. Epub 2011 Jun 14.
A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer.
Iwase H, Shimada M, Tsuzuki T, Ina K, Sugihara M, Haruta J, Shinoda M, Kumada T, Goto H.
Oncology. 2011;80(1-2):76-83. Epub 2011 Jun 10.
Phase II trial of S-1 plus low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902 Step2).
Nakata B, Tsuji A, Mitachi Y, Taenaka N, Kamano T, Oikawa K, Onoda N, Kambe M, Takahashi M, Shirasaka T, Morita S, Sakamoto J, Tanaka Y, Saji S, Hirakawa K.
Oncology. 2010;79(5-6):337-42. Epub 2011 Mar 23.
Phase I study of biweekly intravenous paclitaxel plus intraperitoneal cisplatin and paclitaxel for gastric cancer with peritoneal metastasis.
Ishigami H, Kitayama J, Kaisaki S, Yamaguchi H, Yamashita H, Emoto S, Nagawa H.
Oncology. 2010;79(3-4):269-72. Epub 2011 Mar 4.
Improvement of oral intake following chemotherapy in gastric cancer patients with an inability to eat.
Shitara K, Ito S, Sawaki A, Tajika M, Kawai H, Yokota T, Takahari D, Ura T, Muro K.
Oncology. 2010;79(3-4):211-8. Epub 2011 Mar 1.
Adjuvant chemotherapy with etoposide, adriamycin and cisplatin compared with surgery alone in the treatment of gastric cancer: a phase III randomized, multicenter, clinical trial.
Kulig J, Kolodziejczyk P, Sierzega M, Bobrzynski L, Jedrys J, Popiela T, Dadan J, Drews M, Jeziorski A, Krawczyk M, Starzynska T, Wallner G.
Oncology. 2010;78(1):54-61. Epub 2010 Mar 6.
Weekly intravenous and intraperitoneal paclitaxel combined with S-1 for malignant ascites due to advanced gastric cancer.
Kitayama J, Ishigami H, Kaisaki S, Hidemura A, Kato M, Otani K, Kamei T, Soma D, Miyato H, Yamashita H, Nagawa H.
Oncology. 2010;78(1):40-6. Epub 2010 Mar 3.
Targeted HER2 treatment in advanced gastric cancer.
Jørgensen JT.
Oncology. 2010;78(1):26-33. Epub 2010 Feb 25.
A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas.
Lo SS, Khorana AA, Javle M, Simon S, Kiefer G, Rajasenan K, Wang H, Hantel A, Shayne M, Hwang J, Schmotzer A, Ramanathan RK.
Oncology. 2010;78(2):125-9. Epub 2010 Apr 13.
The standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinoma.
Murthy SB, Patnana SV, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinlac HA, Wang X, Ajani JA.
Oncology. 2010;78(5-6):316-22. Epub 2010 Aug 11.
Rechallenge with platinum plus fluoropyrimidine +/- epirubicin in patients with oesophagogastric cancer.
Okines AF, Asghar U, Cunningham D, Ashley S, Ashton J, Jackson K, Hawkes E, Chau I.
Oncology. 2010;79(1-2):150-8. Epub 2010 Dec 8.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on